120 related articles for article (PubMed ID: 10989193)
1. Trimidox, an inhibitor of ribonucleotide reductase, induces apoptosis and activates caspases in HL-60 promyelocytic leukemia cells.
Fritzer-Szekeres M; Grusch M; Luxbacher C; Horvath S; Krupitza G; Elford HL; Szekeres T
Exp Hematol; 2000 Aug; 28(8):924-30. PubMed ID: 10989193
[TBL] [Abstract][Full Text] [Related]
2. Apoptosis-inducing cleavage of caspases by trimidox, an inhibitor of ribonucleotide reductase.
Fritzer-Szekeres M; Luxbacher C; Horvath Z; Grusch M; Krupitza G; Elford HL; Szekeres T
Adv Exp Med Biol; 2000; 486():125-30. PubMed ID: 11783468
[No Abstract] [Full Text] [Related]
3. The ribonucleotide reductase inhibitor trimidox induces c-myc and apoptosis of human ovarian carcinoma cells.
Rosenberger G; Fuhrmann G; Grusch M; Fassl S; Elford HL; Smid K; Peters GJ; Szekeres T; Krupitza G
Life Sci; 2000 Nov; 67(26):3131-42. PubMed ID: 11191620
[TBL] [Abstract][Full Text] [Related]
4. Trimidox, an inhibitor of ribonucleotide reductase, synergistically enhances the inhibition of colony formation by Ara-C in HL-60 human promyelocytic leukemia cells.
Fritzer-Szekeres M; Salamon A; Grusch M; Horvath Z; Höchtl T; Steinbrugger R; Jäger W; Krupitza G; Elford HL; Szekeres T
Biochem Pharmacol; 2002 Aug; 64(3):481-5. PubMed ID: 12147300
[TBL] [Abstract][Full Text] [Related]
5. Activation of caspases and induction of apoptosis by novel ribonucleotide reductase inhibitors amidox and didox.
Grusch M; Fritzer-Szekeres M; Fuhrmann G; Rosenberger G; Luxbacher C; Elford HL; Smid K; Peters GJ; Szekeres T; Krupitza G
Exp Hematol; 2001 May; 29(5):623-32. PubMed ID: 11376876
[TBL] [Abstract][Full Text] [Related]
6. Trimidox induces apoptosis via cytochrome c release in NALM-6 human B cell leukaemia cells.
Kanno S; Uwai K; Tomizawa A; Hiura T; Osanai Y; Ujibe M; Takeshita M; Ohtake T; Kimura K; Ishikawa M
Basic Clin Pharmacol Toxicol; 2006 Jan; 98(1):44-50. PubMed ID: 16433890
[TBL] [Abstract][Full Text] [Related]
7. Synthetic 1,4-anthracenedione analogs induce cytochrome c release, caspase-9, -3, and -8 activities, poly(ADP-ribose) polymerase-1 cleavage and internucleosomal DNA fragmentation in HL-60 cells by a mechanism which involves caspase-2 activation but not Fas signaling.
Perchellet EM; Wang Y; Weber RL; Sperfslage BJ; Lou K; Crossland J; Hua DH; Perchellet JP
Biochem Pharmacol; 2004 Feb; 67(3):523-37. PubMed ID: 15037204
[TBL] [Abstract][Full Text] [Related]
8. Trimidox-induced apoptosis is mediated through induction of p53 in NALM-6 cells.
Kanno S; Ohtake T; Osanai Y; Kurauchi K; Ujibe M; Uwai K; Takeshita M; Satoh S; Ishikawa M
J Pharmacol Sci; 2008 Mar; 106(3):521-4. PubMed ID: 18344606
[TBL] [Abstract][Full Text] [Related]
9. Iron binding capacity of trimidox (3,4,5-trihydroxybenzamidoxime), a new inhibitor of the enzyme ribonucleotide reductase.
Szekeres T; Vielnascher E; Novotny L; Vachalkova A; Fritzer M; Findenig G; Göbl R; Elford HL; Goldenberg H
Eur J Clin Chem Clin Biochem; 1995 Nov; 33(11):785-9. PubMed ID: 8620054
[TBL] [Abstract][Full Text] [Related]
10. [The ribonucleotide reductase enzyme as a target for enzyme-directed chemotherapy effects of trimidox (3,4,5-trihydroxybenzohydroxamidoxim), a new inhibitor of ribonucleotide reductases].
Findenig G; Vielnascher E; Göbl R; Fritzer-Szekeres M; Szekeres T
Wien Klin Wochenschr; 1995; 107(22):694-7. PubMed ID: 8533431
[TBL] [Abstract][Full Text] [Related]
11. Apicidin, a histone deacetylase inhibitor, induces apoptosis and Fas/Fas ligand expression in human acute promyelocytic leukemia cells.
Kwon SH; Ahn SH; Kim YK; Bae GU; Yoon JW; Hong S; Lee HY; Lee YW; Lee HW; Han JW
J Biol Chem; 2002 Jan; 277(3):2073-80. PubMed ID: 11698395
[TBL] [Abstract][Full Text] [Related]
12. Synergistic growth inhibitory and differentiating effects of trimidox and tiazofurin in human promyelocytic leukemia HL-60 cells.
Szekeres T; Fritzer M; Strobl H; Gharehbaghi K; Findenig G; Elford HL; Lhotka C; Schoen HJ; Jayaram HN
Blood; 1994 Dec; 84(12):4316-21. PubMed ID: 7994048
[TBL] [Abstract][Full Text] [Related]
13. Enhanced effects of adriamycin by combination with a new ribonucleotide reductase inhibitor, trimidox, in murine leukemia.
Fritzer-Szekeres M; Novotny L; Romanova D; Göbl R; Sedlak J; Vachalkova A; Rauko P; Elford HL; Szekeres T
Life Sci; 1998; 63(7):545-52. PubMed ID: 9718080
[TBL] [Abstract][Full Text] [Related]
14. Biochemical and antitumor activity of trimidox, a new inhibitor of ribonucleotide reductase.
Szekeres T; Gharehbaghi K; Fritzer M; Woody M; Srivastava A; van't Riet B; Jayaram HN; Elford HL
Cancer Chemother Pharmacol; 1994; 34(1):63-6. PubMed ID: 8174204
[TBL] [Abstract][Full Text] [Related]
15. Antitumor triptycene bisquinones induce a caspase-independent release of mitochondrial cytochrome c and a caspase-2-mediated activation of initiator caspase-8 and -9 in HL-60 cells by a mechanism which does not involve Fas signaling.
Perchellet EM; Wang Y; Weber RL; Lou K; Hua DH; Perchellet JP
Anticancer Drugs; 2004 Nov; 15(10):929-46. PubMed ID: 15514562
[TBL] [Abstract][Full Text] [Related]
16. Gallic acid inhibits ribonucleotide reductase and cyclooxygenases in human HL-60 promyelocytic leukemia cells.
Madlener S; Illmer C; Horvath Z; Saiko P; Losert A; Herbacek I; Grusch M; Elford HL; Krupitza G; Bernhaus A; Fritzer-Szekeres M; Szekeres T
Cancer Lett; 2007 Jan; 245(1-2):156-62. PubMed ID: 16488533
[TBL] [Abstract][Full Text] [Related]
17. alpha-fetoprotein causes apoptosis in tumor cells via a pathway independent of CD95, TNFR1 and TNFR2 through activation of caspase-3-like proteases.
Dudich E; Semenkova L; Dudich I; Gorbatova E; Tochtamisheva N; Tatulov E; Nikolaeva M; Sukhikh G
Eur J Biochem; 1999 Dec; 266(3):750-61. PubMed ID: 10583368
[TBL] [Abstract][Full Text] [Related]
18. Involvement of mitochondria and caspase-3 in ET-18-OCH(3)-induced apoptosis of human leukemic cells.
Gajate C; Santos-Beneit AM; Macho A; Lazaro Md; Hernandez-De Rojas A; Modolell M; Muñoz E; Mollinedo F
Int J Cancer; 2000 Apr; 86(2):208-18. PubMed ID: 10738248
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of hemoglobin and F-cell production by targeting growth inhibition and differentiation of K562 cells with ribonucleotide reductase inhibitors (didox and trimidox) in combination with streptozotocin.
Iyamu WE; Adunyah SE; Fasold H; Horiuchi K; Elford HL; Asakura T; Turner EA
Am J Hematol; 2000 Apr; 63(4):176-83. PubMed ID: 10706760
[TBL] [Abstract][Full Text] [Related]
20. Hydroxyurea and trimidox enhance the radiation effect in human pancreatic adenocarcinoma cells.
Leyden D; Ahmed N; Hassan HT
Anticancer Res; 2000; 20(1A):133-8. PubMed ID: 10769645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
